Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license a...Read more
Mylan signs a settlement agreement with OSI Pharma
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Jap...Read more
India bans pain killer 36 years after the US did so
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013
New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks assoc...Read more
Beximco Pharma enters EU market
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredie...Read more
Glenmark's new generic gets FDA nod
Generics | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015
Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Admin...Read more
Amneal pharma to acquire Actavis Australia's generic business
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2015
Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...Read more
ANI pharma, IDT Australia to commercialize US generic drugs
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2015
Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...Read more
Brickell Biotech-Kaken Pharma to co-develop dermatology drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2015
Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development ...Read more
Lupin scouts for acquisitions across the world
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions ac...Read more
US rheumatoid arthritis market to reach $9.3 bn by 2020'
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 02 Apr, 2015
Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9...Read more
BioSpectrum announces the hits and misses of 2013
Generics | Analysis | By BioSpectrum Bureau | 9 Comment | 02 Jan, 2014
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...Read more
Teva proposes to buy Mylan for $40.1 billion
Generics | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2015
Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about ...Read more
Teva's Potential $40 bn Mylan acquisition could transform generics space'
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 27 Apr, 2015
Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is cruc...Read more
TB claims 74000 children each year: WHO
Generics | Analysis | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2013
Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to preve...Read more
Boehringer, Lilly diabetes drug shows +ve results
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013
Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...Read more
Indian drugmakers shifting R&D to South East Asia
Generics | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical in...Read more
Unlike FDA, Indian regulators finds no violations at Ranbaxy
Generics | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, i...Read more
Pfizer, Hisun launch generics joint venture in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the la...Read more